I'm an Optimist, but Also Really Scary to See What Happens Next?

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

i think we're just at the start, and e'll be fascinating, but also really scary to see what happens next. The other thing i'm hearing about is that this chloraquin, the z pack, a xanthro micine, s ithink, i can pronounce it. And then zinc. This treatment, there's been some scattered reports tat people are giving this treatment when they first have symptoms and seeing a hundred % recovery rate. Nthes ar, anecdotal on small samples. But i think that's the other thing that happens, and one of the reasons why we are having a hard time judging the the data coming out of china is probably very hard to

1:00 Jason intros Figma’s Dylan Field & Dylan explains why WebGL was crucial to Figma’s creation
7:09 Why ChromeOS is flourishing in schools
11:28 Who are Figma’s competitors & how do they compare
14:12 How does multiplayer mode work on Figma?
17:29 What does Figma charge, Dylan’s thoughts on charging for SaaS: bottom-up or top-down?
30:26 Is SaaS burnout real? Active-user pricing vs. Passive-user pricing & the importance of increasing pricing transparency
34:41 Becoming a Thiel Fellow, meeting Jason at Foo Camp, what happened between Mahalo & Google?
44:52 Jason goes deeper on what happened at Mahalo
46:33 Why Figma releases new features so quickly, the open-design theory & how it makes Figma anti-fragile
48:42 How is Figma handling COVID-19 on an internal & external basis
1:02:39 Figma’s funding history, why Index led the Seed, why Greylock initially passed & wound up investing
1:08:13 Why Kleiner Perkins invested & why Sequoia passed on the Series B & wound up investing, importance of getting to know your lead investors
1:11:05 How Dylan preps for & leads Figma’s board meetings
1:12:05 How working from home has given bosses better insights into who is actually making major impacts